Testing effectiveness (Phase 2)Looking for participantsNCT04929028
What this trial is testing
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
Who this might be right for
AIDS-Related Anal CarcinomaAnal Margin Squamous Cell CarcinomaAnal Non-Keratinizing Squamous Cell Carcinoma+7 more
National Cancer Institute (NCI) 40